Skip to main content
Log in

The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease

  • Pharmacodynamics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

To investigate whether leptin receptor (LEPR) 223A>G polymorphism influences serum lipid levels and whether this polymorphism affects the effectiveness of simvastatin in Chinese patients with coronary heart disease (CHD).

Methods

A total of 312 patients with CHD were treated with simvastatin 20 mg/day. Fasting serum lipids were determined before and after 12 weeks of treatment.

Results

Patients with AA genotype had significantly higher total cholesterol (TC) levels and lower high-density lipoprotein cholesterol (HDL-C) levels than those with GG genotype (P < 0.05) before simvastatin treatment. In addition, the ability of simvastatin to increase HDL-C levels was significantly lower in patients with AA genotype than those with GG genotype (P < 0.05).

Conclusions

The 223A>G polymorphism of LEPR significantly modulates the HDL-C response to simvastatin in Chinese patients with CHD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wenger NK, Shaw LJ, Vaccarino V (2008) Coronary heart disease in women: update 2008. Clin Pharmacol Ther 83:37–51

    Article  PubMed  CAS  Google Scholar 

  2. Ades PA, Savage PD, Toth MJ, Schneider DJ, Audelin MC, Bunn JY, Ludlow M (2008) The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease. Int J Obes 32:967–974

    Article  CAS  Google Scholar 

  3. Ahima RS, Lazar MA (2008) Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22:1023–1031

    Article  PubMed  CAS  Google Scholar 

  4. Bingham NC, Anderson KK, Reuter AL, Stallings NR, Parker KL (2008) Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology 149:2138–2148

    Article  PubMed  CAS  Google Scholar 

  5. Gulturk S, Cetin A, Erdal S (2008) Association of leptin with insulin resistance, body composition, and lipid parameters in postmenopausal women and men in type 2 diabetes mellitus. Saudi Med J 29:813–820

    PubMed  Google Scholar 

  6. Nelson SM, Freeman DJ, Sattar N, Johnstone FD, Lindsay RS (2007) IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes. Diabetes 56:2705–2709

    Article  PubMed  CAS  Google Scholar 

  7. Baratta R, Amato S, Degano C, Farina MG, Patane G, Vigneri R, Frittitta L (2004) Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89:2665–2671

    Article  PubMed  CAS  Google Scholar 

  8. Dudakovic A, Wiemer AJ, Lamb KM, Vonnahme LA, Dietz SE, Hohl RJ (2008) Inhibition of geranylgeranyl diphosphate synthase induces apoptosis through multiple mechanisms and displays synergy with inhibition of other isoprenoid biosynthetic enzymes. J Pharmacol Exp Ther 324:1028–1036

    Article  PubMed  CAS  Google Scholar 

  9. Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP (2008) Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. Curr Med Res Opin 24:249–259

    Article  PubMed  CAS  Google Scholar 

  10. Myerson M, Ngai C, Jones J, Holleran S, Ramakrishnan R, Berglund L, Ginsberg HN (2005) Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia. J Lipid Res 46:2735–2744

    Article  PubMed  CAS  Google Scholar 

  11. Kajinami K, Takekoshi N, Brousseau ME, Schaefer EJ (2004) Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management. Atherosclerosis 177:219–234

    Article  PubMed  CAS  Google Scholar 

  12. Popko K, Gorska E, Wasik M, Stoklosa A, Plywaczewski R, Winiarska M, Gorecka D, Sliwinski P, Demkow U (2007) Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnea patients. J Physiol Pharmacol 58:551–561

    PubMed  Google Scholar 

  13. Van der Vleuten GM, Kluijtmans LA, Hijmans A, Blom HJ, Stalenhoef AF, de Graaf J (2006) The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia. Int J Obes 30:892–898

    Article  Google Scholar 

  14. Arca M (2007) Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome. Drugs 67:43–54

    Article  PubMed  CAS  Google Scholar 

  15. Keating GM, Robinson DM (2008) Rosuvastatin: a review of its effect on atherosclerosis. Am J Cardiovasc Drugs 8:127–146

    PubMed  CAS  Google Scholar 

  16. Tachibana-Iimori R, Tabara Y, Kusuhara H, Kohara K, Kawamoto R, Nakura J, Tokunaga K, Kondo I, Sugiyama Y, Miki T (2004) Effect of genetic polymorphism of OATP-C(SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. Drug Metab Pharmacokinet 19:375–380

    Article  PubMed  CAS  Google Scholar 

  17. Morton NM, Emilsson V, de Groot P, Pallett AL, Cawthorne MA (1999) Leptin signalling in pancreatic islets and clonal insulin-secreting cells. J Mol Endocrinol 22:173–184

    Article  PubMed  CAS  Google Scholar 

  18. Stefan N, Vozarova B, Del Parigi A, Ossowski V, Thompson DB, Hanson RL, Ravussin E, Tataranni PA (2002) The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obesity Relat Metab Disord 26:1629–1632

    Article  CAS  Google Scholar 

  19. Coenen KR, Gruen ML, Hasty AH (2007) Obesity causes very low density lipoprotein clearance defects in low-density lipoprotein receptor-deficient mice. J Nutr Biochem 18:727–735

    Article  PubMed  CAS  Google Scholar 

  20. Begriche K, Letteron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B (2008) Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am J Physiol Endocrinol Metab 294:E939–E951

    Article  PubMed  CAS  Google Scholar 

  21. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430

    Article  PubMed  CAS  Google Scholar 

  22. Jiao S, Matsuzawa Y, Matsubara K, Kubo M, Tokunaga K, Odaka H, Ikeda H, Matsuo T, Tarui S (1991) Abnormalities of plasma lipoproteins in a new genetically obese rat with non-insulin-dependent diabetes mellitus (Wistar fatty rat). Int J Obesity 15:487–495

    CAS  Google Scholar 

  23. VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE (2001) Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol 281:G393–404

    PubMed  CAS  Google Scholar 

  24. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339–343

    Article  PubMed  CAS  Google Scholar 

  25. Mendez-Sanchez N, Gonzalez V, King-Martinez AC, Sanchez H, Uribe M (2002) Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss. J Nutr 132:2195–2198

    PubMed  CAS  Google Scholar 

  26. Wu ZH, Zhao SP, Ye HJ (2006) The beneficial effects of high-density lipoprotein on adipocytes may relate to its anti-atherogenic properties. Med Hypotheses 67:1195–1199

    Article  PubMed  CAS  Google Scholar 

  27. Soro A, Jauhiainen M, Ehnholm C, Taskinen MR (2003) Determinants of low HDL levels in familial combined hyperlipidemia. J Lipid Res 44:1536–1544

    Article  PubMed  CAS  Google Scholar 

  28. Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI (2001) A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet 108:233–236

    Article  PubMed  CAS  Google Scholar 

  29. Kullo IJ, Turner ST, Boerwinkle E, Kardia SL, de Andrade AM (2005) A novel quantitative trait locus on chromosome 1 with pleiotropic effects on HDL-cholesterol and LDL particle size in hypertensive sibships. Am J Hypertens 18:1084–1090

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lan-Feng Wang.

Additional information

Yan-Ming Sun and Jia Li contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, YM., Wang, LF., Li, J. et al. The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease. Eur J Clin Pharmacol 65, 157–161 (2009). https://doi.org/10.1007/s00228-008-0578-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-008-0578-3

Keywords

Navigation